Activation of Src kinase by protein–tyrosine phosphatase–PEST in osteoclasts: Comparative analysis of the effects of bisphosphonate and protein–tyrosine phosphatase inhibitor on Src activation in vitro
- 6 April 2009
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 220 (2) , 382-393
Abstract
PTP–PEST is involved in the regulation of sealing ring formation in osteoclasts. In this article, we have shown a regulatory role for PTP–PEST on dephosphorylation of c‐Src at Y527 and phosphorylation at Y418 in the catalytic site. Activation of Src in osteoclasts by over‐expression of PTP–PEST resulted in the phosphorylation of cortactin at Y421 and WASP at Y294. Also enhanced as a result, is the interaction of Src, cortactin, and Arp2 with WASP. Moreover, the number of osteoclasts displaying sealing ring and bone resorbing activity was increased in response to PTP–PEST over‐expression as compared with control osteoclasts. Cells expressing constitutively active‐Src (527YΔF) simulate the effects mediated by PTP–PEST. Treatment of osteoclasts with a bisphosphonate alendronate or a potent PTP inhibitor PAO decreased the activity and phosphorylation of Src at Y418 due to reduced dephosphorylation state at Y527. Therefore, Src‐mediated phosphorylation of cortactin and WASP as well as the formation of WASP·cortactin·Arp2 complex and sealing ring were reduced in these osteoclasts. Similar effects were observed in osteoclasts treated with an Src inhibitor PP2. We have shown that bisphosphonates could modulate the function of osteoclasts by inhibiting downstream signaling mediated by PTP–PEST/Src, in addition to its effect on the inhibition of the post‐translational modification of small GTP‐binding proteins such as Rab, Rho, and Rac as shown by others. The promising effects of the inhibitors PP2 and PAO on osteoclast function suggest a therapeutic approach for patients with bone metastases and osteoporosis as an alternative to bisphosphonates. J. Cell. Physiol. 220: 382–393, 2009.Keywords
This publication has 72 references indexed in Scilit:
- Dramatic inhibition of osteoclast sealing ring formation and bone resorption in vitro by a WASP-peptide containing pTyr294 amino acidJournal of Molecular Signaling, 2008
- Src phosphorylation of cortactin enhances actin assemblyProceedings of the National Academy of Sciences, 2007
- Syk, c-Src, the αvβ3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorptionJournal of Cell Biology, 2007
- Cortactin Has an Essential and Specific Role in Osteoclast Actin AssemblyMolecular Biology of the Cell, 2006
- Regulation of Actin Ring Formation by Rho GTPases in OsteoclastsJournal of Biological Chemistry, 2005
- Cortactin regulates cell migration through activation of N-WASPJournal of Cell Science, 2005
- The role of dynamin in the assembly and function of podosomes and invadopodiaFrontiers in Bioscience-Landmark, 2004
- Inhibition of the Activity of Src and Abl Tyrosine Protein Kinases by the Binding of the Wiskott−Aldrich Syndrome ProteinBiochemistry, 2003
- Tyrosine Phosphatase-ε Activates Src and Supports the Transformed Phenotype of Neu-induced Mammary Tumor CellsJournal of Biological Chemistry, 2003
- Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex.Journal of Cell Biology, 1993